language_icon
EN
HI

Dr Reddy's Laboratories. Share price

DRREDDY

1265.3

4.70 (-0.37%)
NSE
BSE
Last updated on 13 May, 2026 | 15:46 IST
Today's High

1303.80

Today's Low

1230.00

52 Week Low

1138.50

52 Week High

1379.70

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Dr Reddy's Laboratories Chart

Dr Reddy's Laboratories. Share Key Metrics

Volume
92.76 L
Market Cap
105607.38 CR
LTQ@LTP
2@1265.30
ATP
1269.15
Var Margin
12.92 %
Circuit Range
1143-1397
Delivery %
43.57 %
Value
1177.27 CR
ASM/GSM
No
Market Lot
1

Summary

Dr Reddy's Laboratories. share price stands at ₹1265.3 at 13 May, 2026 | 15:46. The stock Dr Reddy's Laboratories. intraday movement has stayed between ₹1230.00 and ₹1303.80, while on a 52-week basis it has fluctuated from ₹1138.50 to ₹1379.70.
In terms of trading activity, Dr Reddy's Laboratories. has recorded a volume of 9276074 shares. The Dr Reddy's Laboratories. has a market cap of ₹834643020. The stock’s Average Traded Price (ATP) stands at ₹126915, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2, 126530.
The Dr Reddy's Laboratories. operates within a circuit range of ₹1143-1397 – ₹1143-1397, with a Value of ₹1177.27 CR. The Delivery Percentage for the day is 43.57%. Additionally, Dr Reddy's Laboratories. currently falls under the No framework, and trades with a market lot size of 1.

Dr Reddy's Laboratories. Fundamentals

View More
P/E Ratio

25.26

P/B Ratio

2.85

Div. Yield

0.63

Sector P/E

67.07

Sector P/B

3.49

Sec. Div. Yield

0.57

Dr Reddy's Laboratories. Resistance and Support

Pivot 1274.27

Resistance

First Resistance

1284.04

Second Resistance

1298.07

Third Resistance

1307.84

Support

First Support

1260.24

Second Support

1250.47

Third Support

1236.44

Dr Reddy's Laboratories. Futures & Options

link_white_icon

Dr Reddy's Laboratories. Option Chain

View Price, OI, Greeks & More...
View All

26MAY26

1274.00

6.00 (0.47%)

30JUN26

1269.00

1.70 (0.13%)

28JUL26

1262.80

-1.90 (0.15%)

DRREDDY|26MAY26 CE 1260.00

32.20

-10.95 (-25.38%)

DRREDDY|26MAY26 PE 1270.00

26

-14.3 (-35.48%)

Dr Reddy's Laboratories. Shareholding Pattern

View More
  • 2016-17
  • 2017-18
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

26.64%

Mutual Fund

11.14%

Insurance

8.96%

Foreign Institutional Investors

26.85%

Domestic Institutional Investors

2.79%

Retail

10.38%

Others

13.24%

Total Promoters
MAR '24
26.65%
JUN '24
26.65%
SEP '24
26.64%
DEC '24
26.64%

Dr Reddy's Laboratories. Corporate Actions

DateAgenda
2026-05-12Audited Results
2026-01-21Quarterly Results
2025-10-24Quarterly Results
2025-07-23Quarterly Results
2025-05-09Audited Results
2025-01-23Quarterly Results

Dr Reddy's Laboratories. News

Dr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Dr. Reddy's Laboratories made available the audio recording of its earnings call held on May 12, 2026. The call reviewed the company's performance for the quarter ended March 31, 2026, providing insights into its latest financial results.
May 12 2026 23:05:00

Dr Reddys Laboratories Ltd - 500124 - Corporate Action-Board to consider Dividend

Dr. Reddy's Laboratories recommended a final dividend of ₹8 per equity share for FY26. The dividend is subject to shareholder approval at the AGM, with a record date of July 10, 2026.
May 12 2026 17:05:00

Dr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Change in Management

Dr. Reddy's Laboratories has elevated Mr. Sandeep Khandelwal, Global Generics India Head, to Senior Management Personnel, inducting him into the Management Council. Khandelwal significantly grew the India business from Rs.2,300 crore to Rs.7,000 crore.
May 12 2026 17:05:00

Dr Reddys Laboratories Ltd - 500124 - Fixing Of Record Date As July 10, 2026 For The Purpose Of Payment Of Final Dividend For FY 2025-26

Dr. Reddy's Laboratories fixed July 10, 2026, as the record date for its final dividend of ₹8.00 per equity share for FY26. Payment is subject to shareholder approval at the upcoming AGM.
May 12 2026 16:05:00

Dr Reddys Laboratories Ltd - 500124 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 12, 2026

Dr. Reddy's Laboratories reported Q4 FY26 cons. revenue of ₹7,516 cr (down 11.6% YoY) and net profit of ₹220 cr (down 86% YoY). The Board also recommended a final dividend of ₹8 per equity share for FY26.
May 12 2026 16:05:00

Dr Reddys Laboratories Ltd - 500124 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dr. Reddy's Laboratories management is scheduled to participate in investor group meetings with HSBC in Mumbai from May 14-15, 2026, and with Bank of America in Singapore from May 18-19, 2026. These meetings are part of routine investor engagement.
May 11 2026 21:05:00

Dr Reddys Laboratories Ltd - 500124 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Dr. Reddy's Laboratories received Health Canada approval for its generic Semaglutide Injection, authorizing its commercialization, sale, and distribution in Canada. This marks a significant milestone as it's the first company to obtain such authorization in Canada.
Apr 29 2026 09:04:00

Dr Reddys Laboratories Ltd - 500124 - Board Meeting Intimation For Recommending Final Dividend, If Any, For The Financial Year 2025-26

Dr. Reddy's Laboratories board will consider recommending a final dividend for FY 2025-26. This decision will be made during an upcoming board meeting, following a prior intimation from March 23, 2026.
Apr 16 2026 15:04:00
Read More

About Dr Reddy's Laboratories.

NSE : 881  
BSE : 500124  
ISIN : INE089A01031  

Dr Reddy's Laboratories. Management

NamePosition
K Randhir SinghCompany Secretary, Compliance Officer and Head-CSR
K Satish ReddyChairman
View More

Dr Reddy's Laboratories. FAQs

The Buying Price of Dr Reddy's Laboratories. share is 1265.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Dr Reddy's Laboratories. stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Dr Reddy's Laboratories., choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Dr Reddy's Laboratories. shares is 25.26. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Dr Reddy's Laboratories. shares is 2.85. Useful to assess the stock's value relative to its book value.

To assess Dr Reddy's Laboratories.’s valuation compare Sector P/E, P/B which are 67.07 & 3.49 with sector averages, along with growth rates and financial metrics.

The Market Cap of Dr Reddy's Laboratories. is 105607.38 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Dr Reddy's Laboratories. share price is 1379.70 & 1138.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Dr Reddy's Laboratories. belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost